Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by neuropathologic changes involving beta-amyloid (Aβ), tau, neuronal loss, and other associated biological events. While levels of cerebrospinal fluid (CSF) Aβ and tau peptides have enhanced the antemortem de...

Descripción completa

Detalles Bibliográficos
Autores principales: Gangishetti, Umesh, Christina Howell, J., Perrin, Richard J., Louneva, Natalia, Watts, Kelly D., Kollhoff, Alexander, Grossman, Murray, Wolk, David A., Shaw, Leslie M., Morris, John C., Trojanowski, John Q., Fagan, Anne M., Arnold, Steven E., Hu, William T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156847/
https://www.ncbi.nlm.nih.gov/pubmed/30253800
http://dx.doi.org/10.1186/s13195-018-0426-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156847/
https://www.ncbi.nlm.nih.gov/pubmed/30253800
http://dx.doi.org/10.1186/s13195-018-0426-3

Ejemplares similares